Patents by Inventor Nicholas P. Gill

Nicholas P. Gill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of Treating Cystic Fibrosis
    Publication number: 20230338340
    Abstract: This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating diseases associated with interaction of proteins with PDZ domain of the CFTR-associated ligand (CAL PDZ or CALP) and/or DH domain on Disabled-2 (Dab2) protein (Dab2-DH). More particularly, this disclosure relates to methods of treating cystic fibrosis.
    Type: Application
    Filed: April 26, 2023
    Publication date: October 26, 2023
    Inventors: Nicholas P. GILL, Dean R. MADDEN, Moises CHAVEZ, Sahar AL-AYYOUBI, Patrick R. CUSHING, Yu ZHAO
  • Therapy and kit for the prevention and treatment of cystic fibrosis
    Patent number: 10744180
    Abstract: Compositions, kits and methods for preventing or treating cystic fibrosis are provided, which include the use of a peptidomimetic that inhibits the interaction between CAL and mutant CFTR proteins.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: August 18, 2020
    Assignee: TRUSTEES OF DARTMOUTH COLLEGE
    Inventors: Dean R. Madden, Nicholas P. Gill, Carrie Ann Davison, Mark R. Spaller
  • THERAPY AND KIT FOR THE PREVENTION AND TREATMENT OF CYSTIC FIBROSIS
    Publication number: 20180318382
    Abstract: Compositions, kits and methods for preventing or treating cystic fibrosis are provided, which include the use of a peptidomimetic that inhibits the interaction between CAL and mutant CFTR proteins.
    Type: Application
    Filed: November 22, 2017
    Publication date: November 8, 2018
    Inventors: Dean R. Madden, Nicholas P. Gill, Carrie Ann Davison, Mark R. Spaller